Results 41 to 50 of about 634,140 (212)
Parathyroid carcinoma: an unusual presentation of a rare neoplasm
, 2017 Parathyroid carcinoma is an extremely rare malignant endocrine neoplasm that is very challenging in its diagnosis as well as its treatment. Clinically the disease is detected earlier in patients who present with hyperparathyroidism with signs of profound
Siraj, Fouzia +3 more
core +1 more source
Hepatic metastasis of a parathyroid carcinoma treated with intra-arterial embolization [PDF]
, 2017 This paper reports the case of a patient with parathyroid carcinoma and metastatic parathyroid carcinoma in the liver, as well as persistent hypercalcemia resistant to the management with zoledronic acid and cinacalcet. The patient was treated with intra-
Neira, Fabián +11 more
core +1 more source
Genetic and population analyses implicate thyroid‐related regulation of RNF144B in chondrocalcinosis
Arthritis &Rheumatology, Accepted Article.Objectives Chondrocalcinosis, characterized by calcium crystal deposition within articular cartilage, affects 5–15% of the general population and has recently been identified as an osteoarthritis risk factor. However, Its biological pathways remain unclear.
Yahong Wu +15 more
wiley +1 more source
Current concepts in parathyroid carcinoma: a single Centre experience
BMC Endocrine Disorders, 2019 Background Parathyroid carcinoma is a rare neoplasm that may present sporadically or in the context of a genetic syndrome. Diagnosis and management are challenging due to the lack of clinical and pathological features that may reliably distinguish ...
Valentina Ferraro +9 more
doaj +1 more source
Indonesian Journal of CancerIntroduction: Parathyroid carcinoma is a rare malignant neoplasm. The symptoms that arise are related to hyperparathyroid conditions, which are clinically difficult to distinguish between benign and malignant disorders.
Rupita Sari Endangena Sitanggang +2 more
doaj +1 more source
The Pan African Medical Journal, 2017 Parathyroid carcinomas are rare endocrine tumors which comprise 0.3-5.6% of all causes of hyperparathyroidism. 90% of them are hormonally active, while 10% of them may be non-functional. They mostly occur in a single parathyroid gland.
Kursat Dikmen +7 more
doaj +1 more source
BMC Nephrology, 2017 Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving chronic dialysis therapy. Although cinacalcet can control parathyroid function and bone turnover, preventing ectopic calcification remains challenging ...
Daisuke Takada +4 more
doaj +1 more source
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
British Journal of Clinical Pharmacology, EarlyView.Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
Expression of parathyroid hormone-related protein in gastrointestinal malignancies. [PDF]
, 2006 Parathyroid hormone-related protein (PTHrP) is a peptide hormone which, when abundantly produced by certain tumours, and released into the systemic circulation, stimulates via an endocrine-like pathway, bone resorption and renal calcium reabsorption, by ...
McStay, M.K.G.
core
Ear, Nose & Throat JournalParathyroid carcinoma is a rare endocrine tumor. Parathyroid carcinoma in patients with secondary hyperparathyroidism due to chronic kidney disease is also rare. In addition, thyroid hemiagenesis is a rare congenital anomaly.
Shinpei Kada MD, PhD +2 more
doaj +1 more source